Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
[Dilip Davda] The company is engaged in Ayurvedic Healthcare Products marketing. It does online marketing of its products under D2C model. The company marked steady growth in its top and bottom lines for the reported periods. Based on its recent financial performance, the issue appears fully priced. With its direct marketing strategy, the management is confident of maintaining its margin trends going forward. Investors may park funds for medium to long term. Read detail review...
Sat Kartar Shopping Limited peer comparison with similar listed entities. (As on March 28, 2024)
| Company Name | EPS (Basic) | EPS (Diluted) | P/E (x) | RoNW (%) | Financial statements |
|---|---|---|---|---|---|
| Sat Kartar Shopping Limited | 22.52 | 22.52 | 14.87 | 66.84 | |
| Jeena Sikho Lifecare Limited | 27.84 | 27.84 | 64.9 | Standalone | |
| Kerala Ayurveda Ltd. | -1.47 | -1.47 | -182.66 | Standalone |
Notes:
Sat Kartar Shopping IPO Reviews, analysis and views by popular members. Read Sat Kartar Shopping Ltd. IPO reviews by retail investors to find recommended ipo to buy.
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
Note:
Useful Articles
RHP